Company news
Instil Bio, Inc. news in 2023
Instil Bio, Inc.'s news releases, calls and decks from 2023, newest first.
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
December 4, 2023
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 12, 2023
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
November 5, 2023
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 13, 2023
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
June 25, 2023
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 10, 2023
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
January 30, 2023
Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
January 8, 2023
Decks in 2023
- Technical Presentation (June 2023)
Technical · 14 slides · June 2023